However, the altered activity of TGF-β signaling has been reported to promote a diverse range of disease conditions, including Inflammatory Bowel Disease (IBD) and, subsequently, tumor initiation, progression, and metastasis (30–32). Here, TGFB1 is linked to neoplasm.